Abano Healthcare Group Limited provided earnings guidance for the twelve months ending May 31, 2016. For the year, the company expects gross revenue of $301 million to $305 million and revenue of $211 million to $215 million. Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) are expected to be $25.2 million to $26.4 million.

Net Profit After Tax (NPAT) is expected to be $9.4 million to $10.2 million. The company's Underlying EBITDA is expected to be between $26.1 million to $27.3 million, resulting in an Underlying NPAT between $8.2 million to $9.0 million.